WallStreetZenWallStreetZen

NASDAQ: IXHL
Incannex Healthcare Ltd Stock

$2.09+0.06 (+2.96%)
Updated Mar 29, 2023
IXHL Price
$2.09
Fair Value Price
N/A
Market Cap
$66.18M
52 Week Low
$1.77
52 Week High
$9.67
P/E
-3x
P/B
0.7x
P/S
91.77x
PEG
N/A
Dividend Yield
N/A
Revenue
$788.65k
Earnings
-$18.19M
Gross Margin
121.3%
Operating Margin
-2,306.21%
Profit Margin
-2,306.2%
Debt to Equity
0.01
Operating Cash Flow
-$16M
Beta
0.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IXHL Overview

Incannex Healthcare Ltd develops and sells medicinal cannabinoid products in Australia. It offers pharmaceutical-grade cannabinoid products under the Incannex brand name. Incannex Healthcare has a partnership with The Alfred Hospital and Novotech, and the Monash Trauma Group at the Department of Neuroscience, Monash University. Known as Impression Healthcare Ltd. until 2020, Incannex Healthcare was incorporated in 2001 and is based in Sydney, Australia.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IXHL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IXHL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IXHL is good value based on its book value relative to its share price (0.7x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.81x)
P/B vs Industry Valuation
IXHL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IXHL due diligence checks available for Premium users.

Be the first to know about important IXHL news, forecast changes, insider trades & much more!

IXHL News

Valuation

IXHL fair value

Fair Value of IXHL stock based on Discounted Cash Flow (DCF)
Price
$2.09
Fair Value
$4.10
Undervalued by
49.00%
IXHL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IXHL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3x
Industry
17.87x
Market
21.81x

IXHL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.7x
Industry
1.81x
IXHL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IXHL's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
IXHL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IXHL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$95.2M
Liabilities
$1.3M
Debt to equity
0.01
IXHL's short-term assets ($42.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IXHL's short-term assets ($42.13M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IXHL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
IXHL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IXHL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
IXHL$66.18M+2.56%-3.00x0.70x
HUGE$61.75M+1.89%-3.76x2.34x
UPXI$74.00M-1.20%-25.75x2.00x
THTX$74.73M-3.50%-2.09x-4.47x
RLMD$74.95M+2.05%-0.47x0.53x

Incannex Healthcare Stock FAQ

What is Incannex Healthcare's quote symbol?

NASDAQ: IXHL) Incannex Healthcare trades on the NASDAQ under the ticker symbol IXHL. Incannex Healthcare stock quotes can also be displayed as NASDAQ: IXHL.

If you're new to stock investing, here's how to buy Incannex Healthcare stock.

What is the 52 week high and low for Incannex Healthcare (NASDAQ: IXHL)?

(NASDAQ: IXHL) Incannex Healthcare's 52-week high was $9.67, and its 52-week low was $1.77. It is currently -78.44% from its 52-week high and 17.8% from its 52-week low.

How much is Incannex Healthcare stock worth today?

(NASDAQ: IXHL) Incannex Healthcare currently has 1,587,010,366 outstanding shares. With Incannex Healthcare stock trading at $2.09 per share, the total value of Incannex Healthcare stock (market capitalization) is $66.18M.

Incannex Healthcare stock was originally listed at a price of $14.88 in Mar 2, 2022. If you had invested in Incannex Healthcare stock at $14.88, your return over the last 1 years would have been -85.99%, for an annualized return of -85.99% (not including any dividends or dividend reinvestments).

How much is Incannex Healthcare's stock price per share?

(NASDAQ: IXHL) Incannex Healthcare stock price per share is $2.09 today (as of Mar 29, 2023).

What is Incannex Healthcare's Market Cap?

(NASDAQ: IXHL) Incannex Healthcare's market cap is $66.18M, as of Mar 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Incannex Healthcare's market cap is calculated by multiplying IXHL's current stock price of $2.09 by IXHL's total outstanding shares of 1,587,010,366.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.